News

Cardiosense announced today that it received FDA 510 (k) clearance for its CardioTag wearable sensor device.
These findings suggest modulation of HIF signalling extends epicardial activation to maintain myocardial survival beyond the neonatal regenerative window and may represent a viable strategy for ...